Viemed Healthcare (VMD) shares are -8% YTD and trading relatively flat from 2018 levels with Medtech weak much of 2024 but seeing solid growth and profitable, though some concerns with how GLP-1 impacts its core focus on sleep apnea.
VMD is a provide...